Apache Corporation (APA) climbed 0.77% during last trading as the stock added $0.47 to finish the day at $61.43 with about 3.91M shares changing hands, compared to its three month average trading volume of 3.19M. The $23.46B market cap company, which fluctuated between $60.85 and $61.92 during the day, currently situated 88.04% above its 52 week low of $33.23 and -10.62% away from its one year high of $69. The RSI of 39.16 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.
Apache Corporation, an independent energy company, explores, develops, and produces natural gas, crude oil, and natural gas liquids. It operates onshore and offshore assets primarily in the Permian Basin, the Anadarko basin in western Oklahoma, the Texas Panhandle, and Gulf Coast areas of the United States, as well as in Western Canada and Gulf of Mexico. The company also operates assets in Egypt and the United Kingdom in the North Sea. As of December 31, 2015, it had total estimated proved reserves of 794 million barrels of crude oil, 198 million barrels of natural gas liquids, and 3.4 trillion cubic feet of natural gas. Apache Corporation was founded in 1954 and is based in Houston, Texas.
Exelon Corporation (EXC) gained $0.22 to close the day at a new closing price of $35.35, a 0.63% increase in value from its previous closing price that moved the stock 35.27% above its 52 week low of $27.85. A total of 3.91M shares exchanged hands during the day compared with its three month average trading volume of 6.38M. The stock, which fluctuated between $35.18 and $35.45 during the day, currently situated -4.44% below its 52 week high. The stock is up by 0.11% in the past one month and up by 9.35% over the past three months. With a one year target estimate of $38.42 and RSI of 53.69, the stock still has upside potential, making it a hold for now.
Exelon Corporation, a utility services holding company, engages in the energy generation and delivery businesses in the United States and Canada. It owns electric generating facilities, such as nuclear, fossil, and hydroelectric generation facilities, as well as wind and solar facilities. The company also sells renewable energy and other energy-related products and services; and engages in natural gas and oil exploration and production activities, as well as sells electricity and natural gas to wholesale and retail customers. In addition, it is involved in the purchase and regulated retail sale of electricity, and the provision of electricity transmission and distribution services to retail customers in northern Illinois, southeastern Pennsylvania, and central Maryland. Further, the company engages in the purchase and regulated retail sale of natural gas, and the provision of gas distribution services to retail customers in the Pennsylvania counties surrounding the City of Philadelphia, as well as in central Maryland, including the City of Baltimore. It serves distribution utilities, municipalities, cooperatives, and financial institutions, as well as commercial, industrial, governmental, and residential customers. The company was founded in 1887 and is headquartered in Chicago, Illinois.
Zoetis Inc. (ZTS) had a active trading with around 3.86M shares changing hands compared to its three month average trading volume of 3.4M. The stock traded between $53.73 and $54.29 before closing at the price of $54 with 0.41% change on the day. The Florham Park New Jersey 07932 based company is currently trading 42.29% above its 52 week low of $38.26 and -1.12% below its 52 week high of $54.72. Both the RSI indicator and target price of 62.5 and $57.4 respectively, lead us to believe that it should be put on hold over the coming weeks.
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals in the United States and internationally. It offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites, such as fleas, ticks, and worms. The company also provides medicated feed additives that offer medicines to livestock; veterinarian solutions for anesthesia, pain management, and the diagnosis of diabetes; and other pharmaceutical products, including pain and sedation, oncology, antiemetic, allergy and dermatology, and reproductive products. In addition, it offers other product categories comprising nutritionals and agribusiness services, as well as products and services in complementary areas consisting of biodevices, diagnostics, and genetics. The company markets its products to veterinarians and livestock producers through its sales representatives, and technical and veterinary operations specialists. Zoetis Inc. was founded in 1952 and is headquartered in Florham Park, New Jersey.